A review of immune-related adverse events associated with immunotherapy / 中华肿瘤杂志
Chinese Journal of Oncology
;
(12): 17-21, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-799029
ABSTRACT
Immune checkpoint inhibitors have been approved for clinical application in China. However, the increased immune-related adverse event (irAE) needs more attention. This review summarized the incidence, characteristic clinical manifestation and treatment of irAEs associated with programmed cell death protein-1(PD-1) and programmed cell death ligand-1(PD-L1) inhibitors. To have a deep insight into irAE, the potential mechanisms, the different incidences of cancer types, influencing factors and the direction of future research were also discussed here to provide guidance for clinical oncologist to identify and monitor irAE.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
/
Prognostic study
Language:
Chinese
Journal:
Chinese Journal of Oncology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS